Korean single-center experience with femoral access closure using the ExoSeal device

Table 1 Patient and procedure characteristics

Characteristic	n = 179
Age (yr)	59.4 (20–87)
Men	145 (81)
Hypertension	59 (33)
Diabetes	52 (29.1)
Smoking status
Current smoker	37 (20.7)
Ex-smoker	53 (29.6)
Nonsmoker	89 (49.7)
Alcohol intake	57 (31.8)
Anticoagulation	10 (5.6)
Aspirin	7 (3.9)
Warfarin	1 (0.6)
Heparin	2 (1.1)
Interventional procedure	171 (95.5)
Consecutive	78 (43.6)
TACE for HCC	76 (42.5)
Visceral embolization of gastrointestinal bleeding	2 (1.1)
Single	93 (51.9)
Diagnostic procedure	8 (4.5)
Antegrade puncture	5 (2.8)
ExoSeal
5-Fr	172 (96.1)
6-Fr	6 (3.4)
7-Fr	1 (0.5)

Data are presented as n (%), unless indicated otherwise. HCC: Hepatocellular carcinoma; TACE: Transarterial chemoembolization.